Internationales Congress Centrum (ICC Berlin)
21 September 2009
Hall 3
18.30-20.00
Berlin, Germany

Chair
    Nadia Harbeck, MD, PhD
    University of Cologne
    Cologne, Germany


Faculty Members
    Bella Kaufman, MD 
    Sheba Medical Center
    Tel Hashomer, Israel


    Henrik Lindman, MD, PhD
    Uppsala University Hospital
    Uppsala, Sweden


    David Miles, MD
    Mt Vernon Cancer Center
    London, United Kingdom


    Sunil Verma, MD                    
    Toronto Sunnybrook Regional Cancer Center                
    Toronto, Ontario, Canada

18.30	Welcome, introduction and demographics Nadia Harbeck, MD, PhD
18.40	Can benefits of adjuvant chemotherapy be further improved? Henrik Lindman, MD, PhD
18.55	What is the clinical benefit of adding anti-VEGF therapy to standard treatment for patients with metastatic breast cancer? David Miles, MD
19.10	The role of nurses in the oncology clinic: Optimizing clinical outcomes Nadia Harbeck, MD, PhD
19.20	Do results of gene expression profiles change treatment decisions in early breast cancer? Bella Kaufman, MD
19.35	The future of breast cancer treatment: A change in direction Sunil Verma, MD
19.50	Symposium summary Nadia Harbeck, MD, PhD